Comparable stake leader
Carlyle Group Inc.
SEC ownership of eFFECTOR Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001828522.
Disclosed value leader
Carlyle Group Inc.
Comparable rows
0/21
Latest evidence
13 Jun 2024
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Carlyle Group Inc.
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
13 Jun 2024
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001828522
- Issuer location
- Solana Beach, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of eFFECTOR Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Carlyle Group Inc.
Disclosed value leader
Carlyle Group Inc.
Comparable rows
0/21
Latest evidence
13 Jun 2024
3/4/5
Highest disclosed value: $2,924,612
21 rows are not safely comparable across share classes.
Showing 1-8 of 21 holder rows.
Quick read
Carlyle Group Inc. has the largest disclosed position value at $2.92M.
0 of 21 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Carlyle Group Inc.'s linked filing trail.
Disclosed position value
Top 5
Carlyle Group Inc.
$2.92M
Jonathan D. Root
$2.74M
Column Group II GP, LP
$2.61M
Presidio Management Group X LLC
$2.49M
Locust Walk Sponsor, LLC
$2.46M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 21 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Carlyle Group Inc. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$2,924,612
4,822,114 shares
|
— | 01 Aug 2022 |
| Jonathan D. Root |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$2,744,147
4,524,562 shares
|
— | 02 Dec 2021 |
| Column Group II GP, LP |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$2,613,608
4,309,329 shares
|
— | 25 Aug 2021 |
| Presidio Management Group X LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$2,492,418
4,109,509 shares
|
— | 01 Aug 2022 |
| Locust Walk Sponsor, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$2,460,116
4,056,250 shares
|
— | 25 Aug 2021 |
| SR ONE CAPITAL MANAGEMENT, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,104,688
1,821,415 shares
|
— | 27 Nov 2023 |
| Abingworth LLP |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
40,000 shares
|
— | 06 Oct 2021 |
| Stephen T. Worland |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$58,883
114,987 shares
mixed-class rows
|
— | 15 May 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 21 reporting-owner rows connected to eFFECTOR Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
21
Largest Forms 3/4/5 holder
Carlyle Group Inc.
Net 12M change
$0
Latest report
13 Jun 2024
Recent insider transactions for eFFECTOR Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.